zk 112993 has been researched along with cyclic gmp in 1 studies
| Studies (zk 112993) | Trials (zk 112993) | Recent Studies (post-2010) (zk 112993) | Studies (cyclic gmp) | Trials (cyclic gmp) | Recent Studies (post-2010) (cyclic gmp) |
|---|---|---|---|---|---|
| 25 | 0 | 0 | 22,346 | 333 | 4,062 |
| Protein | Taxonomy | zk 112993 (IC50) | cyclic gmp (IC50) |
|---|---|---|---|
| Phosphodiesterase | Bos taurus (cattle) | 0.1 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 2.4 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Engström, C; Jaeger, R; Sager, G; Ørbo, A | 1 |
1 other study(ies) available for zk 112993 and cyclic gmp
| Article | Year |
|---|---|
Non-genomic effects of progestins--inhibition of cell growth and increased intracellular levels of cyclic nucleotides.
Topics: Antineoplastic Agents; Cell Division; Cell Line, Transformed; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Gonanes; Hormone Antagonists; Humans; Mifepristone; Progestins; Radioimmunoassay; Receptors, Steroid; Time Factors | 2003 |